But considering the low frequency of BCL11B abnormalities in the ATLL cases and the HTLV-I-positive T-cell lines, translational modifications might be responsible for the downregulation of the BCL11B protein. This evidence concerns the gene BCL11B and adult T-cell leukemia/lymphoma.